Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and GI oncology diseases, ...
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, a ...
A heart attack is far from an isolated, acute event. The consequences of an attack can cause serious and lasting damage, ...
Many promising therapies fail because preclinical models do not fully capture the complexity of the human heart. A new review ...
The human heart must constantly adapt to changing demands—a task that requires tightly coordinated molecular shuffling in ...
Researchers have developed a scalable bioreactor-based system to produce cardiac organoids that successfully integrated into ...
No-reflow syndrome can affect people after a heart attack or a medical procedure. Dr Ashok Seth explains why clear arteries ...
Accurately measuring electrical signals and calcium levels in the heart can lead to earlier treatment of potentially fatal conditions, such as heart attack or congestive heart failure. Calcium plays ...
Internal organ tissues often don’t heal after illness or injury and lose some function, such as the heart after a heart attack. UCLA cardiologists have identified a protein that interferes with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results